SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-147058
Filing Date
2006-07-14
Accepted
2006-07-14 17:12:59
Documents
5
Period of Report
2006-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21485
2 AMENDMENT TO THE AMENDED AND RESTATED RIGHTS AGREEMENT dex41.htm EX-4.1 8646
3 SECOND AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN dex101.htm EX-10.1 6447
4 PRESS RELEASE dex991.htm EX-99.1 4961
5 GRAPHIC g42843img-001.jpg GRAPHIC 14151
  Complete submission text file 0001193125-06-147058.txt   62928
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 06963227
SIC: 2836 Biological Products, (No Diagnostic Substances)